City

Beijing (1)

Hong Kong (1)

Kowloon (1)

Xian (1)

Condition

Hyperprolactinaemia (1)

Hyperprolactinemia (1)

Schizophrenia (1)

Schizophrenic Disorder (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

The University of Hong Kong (1)

Collaborator

Capital Medical University (1)

Kowloon Hospital, Hong Kong (1)

Queen Mary Hospital, Hong Kong (1)

Xijing Hospital (1)

Intervention

pgd granules (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

hyperprolactinaemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia, Schizophrenic Disorder, Hyperprolactinemia Trial in China (PGD granules, Placebo)

Completed

Schizophrenia
+3 more

PGD granules
Placebo

Xian, Shanxi, China
+3 more

May 6, 2015